CME Group (NASDAQ:CME) Earns “Buy” Rating from TD Cowen

Posted by Danessa Lincoln on Sep 30th, 2026

CME Group (NASDAQ:CME – Get Free Report)‘s stock had its “buy” rating reiterated by research analysts at TD Cowen in a note issued to investors on Monday, Benzinga reports. They presently have a $292.00 price target on the financial services provider’s stock. TD Cowen’s price objective would indicate a potential upside of 10.15% from the company’s current price.

Several other equities analysts have also recently issued reports on the company. Wall Street Zen raised CME Group from a “strong sell” rating to a “sell” rating in a research note on Saturday, August 29th. Morgan Stanley boosted their target price on CME Group from $324.00 to $330.00 and gave the company an “overweight” rating in a research note on Thursday, July 23rd. Bank of America boosted their target price on CME Group from $226.00 to $230.00 and gave the company an “underperform” rating in a research note on Thursday, July 23rd. Keefe, Bruyette & Woods raised CME Group from a “market perform” rating to an “outperform” rating and set a $305.00 target price on the stock in a research note on Thursday, June 18th. Finally, Barclays reduced their target price on CME Group from $316.00 to $270.00 and set an “equal weight” rating on the stock in a research note on Thursday, July 9th. Nine equities research analysts have rated the stock with a Buy rating, six have issued a Hold rating and three have issued a Sell rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Hold” and an average price target of $289.81.

View Our Latest Stock Analysis on CME

CME Group Trading Up 1.2%

Shares of CME traded up $3.12 during mid-day trading on Monday, hitting $265.10. 2,276,045 shares of the company’s stock traded hands, compared to its average volume of 2,549,362. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.13. CME Group has a 1 year low of $218.31 and a 1 year high of $329.16. The firm has a market capitalization of $95.32 billion, a P/E ratio of 22.49, a PEG ratio of 3.11 and a beta of 0.24. The business’s 50-day moving average price is $270.88 and its 200-day moving average price is $272.63.

CME Group (NASDAQ:CME – Get Free Report) last posted its earnings results on Wednesday, July 22nd. The financial services provider reported $2.99 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.91 by $0.08. CME Group had a return on equity of 15.60% and a net margin of 63.30%.The firm had revenue of $1.71 billion for the quarter, compared to analysts’ expectations of $1.68 billion. During the same period in the previous year, the firm earned $2.96 earnings per share. The business’s revenue was up .8% compared to the same quarter last year. As a group, sell-side analysts forecast that CME Group will post 12.27 EPS for the current fiscal year.

Insider Activity at CME Group

In other news, Director William R. Shepard purchased 293 shares of the company’s stock in a transaction that occurred on Friday, September 25th. The shares were bought at an average cost of $268.76 per share, for a total transaction of $78,746.68. Following the completion of the transaction, the director directly owned 263,289 shares of the company’s stock, valued at $70,761,551.64. This trade represents a 0.11% increase in their position. The acquisition was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director Elizabeth A. Cook sold 500 shares of CME Group stock in a transaction that occurred on Monday, September 14th. The shares were sold at an average price of $280.11, for a total value of $140,055.00. Following the sale, the director owned 17,916 shares in the company, valued at $5,018,450.76. This represents a 2.72% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. 0.30% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On CME Group

Several hedge funds have recently added to or reduced their stakes in the stock. Burkett Financial Services LLC bought a new stake in CME Group in the third quarter worth $62,000. Envestnet Portfolio Solutions Inc. boosted its holdings in CME Group by 16.6% in the second quarter. Envestnet Portfolio Solutions Inc. now owns 70,325 shares of the financial services provider’s stock worth $14,809,000 after acquiring an additional 10,005 shares in the last quarter. Andra AP fonden boosted its holdings in CME Group by 91.5% in the second quarter. Andra AP fonden now owns 91,990 shares of the financial services provider’s stock worth $20,314,000 after acquiring an additional 43,960 shares in the last quarter. Wellington Altus USA Inc. bought a new stake in CME Group in the second quarter worth $49,000. Finally, Anchor Investment Management LLC boosted its holdings in CME Group by 113.0% in the second quarter. Anchor Investment Management LLC now owns 805 shares of the financial services provider’s stock worth $178,000 after acquiring an additional 427 shares in the last quarter. 87.75% of the stock is owned by institutional investors.

Key Headlines Impacting CME Group

Here are the key news stories impacting CME Group this week:

Positive Sentiment: Record soybean futures open interest highlights robust commodities-market participation and could support CME’s transaction-fee revenue. CME Group Sets New Open Interest Record in Soybean Futures
Positive Sentiment: Analysts expect low double-digit bottom-line growth when CME reports third-quarter earnings later this month, raising expectations for continued earnings momentum. What You Need to Know Ahead of CME Group’s Earnings Release
Positive Sentiment: Cambiar Opportunity Fund identified CME as a stock to add on weakness, citing a disconnect between exceptionally high trading volume and the share price. This suggests some institutional investors view recent weakness as an accumulation opportunity. CME Group Adding on Weakness as All-Time High Volume Disconnects From Stock Price
Positive Sentiment: Director William Shepard purchased 293 shares, providing a modest insider-confidence signal, although the transaction is small relative to CME’s market capitalization. CME Group Insider Share Purchase
Neutral Sentiment: Wall Street analysts initiated a “Hold” rating, indicating limited near-term conviction despite CME’s strong business fundamentals. CME Group Stock Now Rated Hold by Wall Street Analysts
Negative Sentiment: A valuation-focused analysis questioned whether CME is fully priced following its push into cryptocurrency futures, suggesting that expected growth may already be reflected in the stock and could limit further upside without stronger results. Is CME Group Fully Priced After Its Crypto Futures Push?

CME Group Company Profile

(Get Free Report)

CME Group Inc operates global derivatives marketplaces that enable customers to manage risk and trade futures and options contracts. Its exchanges offer products linked to interest rates, equity indexes, foreign currencies, agricultural commodities, energy, metals and other asset classes.

The company also provides central counterparty clearing, settlement and related risk-management services for transactions conducted on its markets. In addition, CME Group offers market data, benchmark products and technology services that support trading, analysis and connectivity for financial institutions, businesses, professional traders and other market participants.

CME Group’s history includes the Chicago Board of Trade, founded in 1848, and the Chicago Mercantile Exchange, established in 1898.